Anne Wojcicki: How 23andMe's DNA Testing is Disrupting the Healthcare Industry

Anne Wojcicki: How 23andMe's DNA Testing is Disrupting the Healthcare IndustryПодробнее

Anne Wojcicki: Genomics Pioneer - Transforming Healthcare through Innovation #entrepreneurshipПодробнее

Decoding the DNA Opportunity with Anne Wojcicki (23andMe)Подробнее

23andMe CEO talks privacy, personalized medicine, and how genetics can help predict diseaseПодробнее

How 23andMe is Revolutionizing Healthcare | Ep. 26 | The Inflection PointПодробнее

23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by board resignations: Read the memoПодробнее

23andMe CEO Anne Wojcicki talks genetic testing, her company's goalsПодробнее

23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health techПодробнее

How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went WrongПодробнее

CEO of 23andMe On Disrupting the Healthcare Industry | J.P. MorganПодробнее

23andMe Using Database Analytics to Track Covid SpreadПодробнее

23andMe CEO on coronavirus genetic testПодробнее

23andMe: FDA ruling had huge impactПодробнее

Why the human genome could be health care’s holy grailПодробнее

23andMe CEO Wojcicki on Telehealth, Covid ResearchПодробнее

Why 23andMe CEO Anne Wojcicki Is Raising PricesПодробнее

The Ethics of Unlocking Your Genes | Anne Wojcicki | Big ThinkПодробнее

Co-Founder and CEO of 23andMe | Anne Wojcicki | Talks at GoogleПодробнее

23andme founder on the future of health careПодробнее

Genomes Unlocked: Anne Wojcicki's Vision for 23andMe and the Future of Proactive Healthcare | E1858Подробнее